Early use of Johnson & Johnson's Zytiga extends prostate cancer survival Ruby Khatun Khatun5 Jun 2017 3:15 PM ISTCHICAGO: Adding Johnson & Johnson's Zytiga to standard hormone therapy reduced by nearly 40 percent the chance of death for men newly diagnosed...
FDA Approves New Novo Nordisk Treatment for Patients with Hemophilia Ruby Khatun Khatun5 Jun 2017 3:14 PM ISTPLAINSBORO: Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application for REBINYN®...
Cholamandalam MS General Insurance raises Rs 100 cr via bonds Ruby Khatun Khatun4 Jun 2017 9:50 AM ISTNew Delhi: Cholamandalam MS General Insurance Company has raised Rs 100 crore by floating bonds on a private placement basis.The company issued 1,000...
Zydus Cadila gets USFDA nod for levofloxacin injection Ruby Khatun Khatun4 Jun 2017 9:48 AM ISTNew Delhi: Drug firm Zydus Cadila has received the US health regulator's nod to market levofloxacin injection, used to treat bacterial infections, in...
Pfizer defeats appeals linking Zoloft to birth defects Ruby Khatun Khatun4 Jun 2017 9:44 AM ISTPfizer Inc on Friday defeated an effort to revive more than 300 lawsuits alleging that its antidepressant Zoloft causes cardiac birth defects in...
CEO Richard P. Goudis Transitions to New Role as Herbalife Nutrition CEO Ruby Khatun Khatun4 Jun 2017 9:41 AM ISTLOS ANGELES: Premier global nutrition company, Herbalife, announced the official transition of Richard P. Goudis as the new Chief Executive Officer...
Strides Shasun gets USFDA nod for pain reliever drug Ruby Khatun Khatun3 Jun 2017 10:27 AM ISTNew Delhi: Strides Shasun has got approval from the US health regulator for pain reliever drug ibuprofen.The product will be marketed by Strides...
Vanrx Pharmasystems appoints Shreedhar Instruments as its distributor in India Ruby Khatun Khatun3 Jun 2017 9:50 AM ISTVANCOUVER, British Columbia: Vanrx Pharmasystems, a manufacturer of advanced aseptic filling systems for the pharmaceutical industry, has announced...
Aurobindo Pharma Q4 Net dips 4% to Rs 532 crore Ruby Khatun Khatun3 Jun 2017 9:30 AM ISTNew Delhi: Aurobindo Pharma posted a 4 per cent dip in consolidated net profit at Rs 532.22 crore for the fourth quarter ended March 2017.The company...
Not received any observation from USFDA audit: Claris Lifesciences Ruby Khatun Khatun3 Jun 2017 9:26 AM ISTNew Delhi: Claris Lifesciences underwent an audit by the USFDA for pharmacovigilance in the last week of May and has not received any...
EU approves Biogen's Spinraza for lead genetic cause of infant death Ruby Khatun Khatun3 Jun 2017 9:22 AM ISTBiogen Inc on Thursday said its drug, Spinraza, had secured European Union approval to treat spinal muscular atrophy (SMA), a leading genetic cause of...
Narayana Hrudayalaya Q4FY17 standalone net profit rises 31% Ruby Khatun Khatun2 Jun 2017 6:27 PM ISTBengaluru: Narayana Hrudayalaya Limited, a leading healthcare service provider in India, announced its financial results for the fourth quarter (Q4...
